United Therapeutics Corporation (UTHR)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	984,800	899,800	871,500	728,300	727,300	707,400	630,800	687,400	475,800	462,400	470,900	405,400	514,800	698,300	659,500	757,500	125,200	192,400	166,500	134,300
Revenue (ttm)	US$ in thousands	2,268,200	2,147,800	2,060,800	1,939,800	1,903,900	1,743,300	1,676,600	1,657,700	1,666,900	1,751,900	1,687,000	1,601,600	1,491,500	1,399,000	1,425,300	1,442,500	1,448,800	1,519,100	1,530,300	1,601,200
Net profit margin		43.42%	41.89%	42.29%	37.55%	38.20%	40.58%	37.62%	41.47%	28.54%	26.39%	27.91%	25.31%	34.52%	49.91%	46.27%	52.51%	8.64%	12.67%	10.88%	8.39%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $984,800K ÷ $2,268,200K
= 43.42%

To analyze United Therapeutics Corp's net profit margin over the past eight quarters, we reviewed the data provided in the table. The net profit margin measures the company's profitability by indicating how much of each dollar of revenue is translated into profit after all expenses have been deducted.

We observed fluctuations in United Therapeutics Corp's net profit margin during the mentioned quarters. The net profit margin ranged from a low of 35.27% in Q2 2022 to a high of 42.31% in Q4 2023. The highest margin of 42.31% was achieved in the most recent quarter, indicating the company's efficient cost management and revenue generation relative to the total revenue.

Overall, the trend indicates some variability in the net profit margin performance of United Therapeutics Corp over the quarters. It would be essential to further investigate the factors driving these fluctuations to assess the company's profitability sustainability in the long term.